Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of uncontrolled asthma~* Age ranged from 18 to 77 years~* Nonsmokers~Exclusion Criteria:~* Use of oral corticosteroids, anti-leukotrienes, immunoglobulins, beta blockers, digitalis, amiodarone, antifungals, antidepressants, monoamine oxidase inhibitors and tricyclics during the standardization~* Atrial fibrillation, Flutter, severe and complex tachyarrhythmias atrioventricular block 1,2 and 3~* Diabetes mellitus~* Pregnancy~* Neuropsychiatric diseases~* Pulmonary malformations, tuberculosis, Cystic fibrosis~* Immunosuppressive treatment~* Hospitalization for asthma or respiratory infection in last 30 days~* Severe systemic disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 77 Years
- Healthy Volunteers: f

Study Arms:
- Fixed Combination of Budesonide and formoterol (Type: EXPERIMENTAL): Group 1 (experimental): Fixed Combination of Budesonide and formoterol
- Budesonide (Type: ACTIVE_COMPARATOR): Group 2 (comparator): Budesonide

Based on this trial design, predict the completion outcome and termination type (if applicable).